Cell and Tissue Culture Supplies: Global Strategic Business Report

Global Cell and Tissue Culture Supplies Market to Reach $42.5 Billion by 2030

The global market for Cell and Tissue Culture Supplies estimated at US$20.1 Billion in the year 2022, is projected to reach a revised size of US$42.5 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 10.9% CAGR and reach US$24 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Equipment segment is readjusted to a revised 8.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.5 Billion, While China is Forecast to Grow at 13.9% CAGR

The Cell and Tissue Culture Supplies market in the U.S. is estimated at US$5.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$9.5 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Select Competitors (Total 73 Featured) -

• Avantor, Inc.
• BD Biosciences
• BioIVT
• Cell Culture Technologies
• Corning Inc.
• GE Healthcare Life Sciences
• Irvine Scientific Inc.
• Lonza Group AG
• Merck Millipore GmbH
• MP Biomedicals LLC
• ORIGIO a/s
• PromoCell GmbH
• Sigma-Aldrich Corporation
• Thermo Fischer Scientific Inc.
• Vitrolife AB

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year